Recruiting Hemophilia Studies in Chicago
About Hemophilia Clinical Trials in Chicago
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 1 hemophilia clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 72 participants. Research is being sponsored by Wayne State University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in Chicago — FAQ
Are there hemophilia clinical trials in Chicago?
Yes, there are 1 hemophilia clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 1 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated August 28, 2026 from ClinicalTrials.gov